Ibukron (Ibuprofen 400 mg)

What Is Ibukron and What Is It Used For?

Ibukron is a non-steroidal anti-inflammatory drug (NSAID) containing ibuprofen 400 mg. It works by inhibiting cyclooxygenase (COX) enzymes, reducing the production of prostaglandins that cause pain, inflammation, and fever. Ibukron is prescribed for conditions where lower over-the-counter doses of ibuprofen provide insufficient relief.

Ibuprofen, the active ingredient in Ibukron, belongs to the propionic acid class of NSAIDs and has been widely used in clinical medicine since the 1960s. It is listed on the World Health Organization's (WHO) List of Essential Medicines, reflecting its importance in global healthcare. Ibuprofen's well-established safety and efficacy profile makes it one of the most commonly prescribed analgesic and anti-inflammatory agents worldwide.

Ibukron 400 mg film-coated tablets are typically prescribed when standard over-the-counter doses (200 mg) do not provide adequate pain relief. The 400 mg strength allows for more effective symptom control while maintaining a favorable risk-benefit ratio when used as directed. Following oral administration, ibuprofen is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations reached within 1 to 2 hours. The drug is extensively metabolized in the liver and has an elimination half-life of approximately 2 hours.

The mechanism of action involves non-selective inhibition of both COX-1 and COX-2 enzymes. COX-2 inhibition is primarily responsible for the therapeutic anti-inflammatory and analgesic effects, while COX-1 inhibition accounts for some of the gastrointestinal side effects, as COX-1 plays a protective role in the stomach lining. This dual inhibition provides three distinct therapeutic benefits: analgesia (pain relief), anti-inflammatory activity, and antipyretic (fever-reducing) effects.

Common indications for Ibukron

Ibukron is prescribed for a wide range of painful and inflammatory conditions. Its versatility makes it suitable for both acute and short-term management of various clinical situations:

• Headache and migraine: Effective for tension-type headaches and mild to moderate migraine attacks
• Dental pain: Post-extraction pain, toothache, and post-dental procedure discomfort
• Menstrual pain (dysmenorrhea): Primary dysmenorrhea responds well to ibuprofen due to prostaglandin inhibition
• Musculoskeletal pain: Back pain, sprains, strains, and soft tissue injuries
• Rheumatic conditions: Symptomatic relief in osteoarthritis and rheumatoid arthritis
• Post-operative pain: Mild to moderate pain following minor surgical procedures
• Fever: Reduction of elevated body temperature in adults

What Should You Know Before Taking Ibukron?

Before taking Ibukron, inform your doctor about any history of stomach ulcers, heart disease, kidney or liver problems, asthma, or allergies to NSAIDs. Ibukron is contraindicated in the third trimester of pregnancy, in patients with active gastrointestinal bleeding, and in those with severe heart, liver, or kidney failure.

Like all NSAIDs, Ibukron requires careful patient assessment before initiation. Your prescribing physician should be informed of your complete medical history to determine whether Ibukron is appropriate for you. Certain medical conditions significantly increase the risk of serious adverse effects, and alternative pain management strategies may be more suitable in those cases.

The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have issued specific guidance regarding NSAID use, emphasizing the importance of individualized risk assessment. The goal is always to achieve adequate symptom control while minimizing exposure to potential adverse effects.

Contraindications

Ibukron must not be taken in the following situations:

• Known hypersensitivity: Allergy to ibuprofen, aspirin, or any other NSAID. This includes patients who have experienced asthma, urticaria, or rhinitis triggered by aspirin or other NSAIDs
• Active peptic ulceration or gastrointestinal bleeding: Current or recurrent peptic ulcer disease, or history of two or more episodes of proven ulceration or bleeding
• Severe hepatic failure: Significant liver impairment (Child-Pugh Class C)
• Severe renal failure: Glomerular filtration rate (GFR) below 30 mL/min
• Severe heart failure: NYHA Class III-IV heart failure
• Third trimester of pregnancy: Risk of premature closure of the ductus arteriosus and inhibition of uterine contractions
• History of NSAID-related gastrointestinal hemorrhage or perforation

Warnings and Precautions

Ibukron should be used with caution in the following patient groups. Your doctor will weigh the benefits against the potential risks and may require additional monitoring:

• Cardiovascular risk: NSAIDs may increase the risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke. This risk may increase with duration of use. Patients with existing cardiovascular disease or risk factors require careful assessment
• Gastrointestinal risk: Risk of bleeding, ulceration, and perforation increases with higher doses and longer treatment duration. Elderly patients are at particularly elevated risk. Co-prescription of a proton pump inhibitor (PPI) should be considered for at-risk patients
• Renal impairment: NSAIDs reduce renal blood flow by inhibiting prostaglandin synthesis. Patients with pre-existing renal insufficiency, dehydration, or concomitant use of diuretics or ACE inhibitors are at increased risk of acute kidney injury
• Hepatic impairment: Ibuprofen is extensively metabolized in the liver. Patients with mild to moderate hepatic dysfunction may require dose adjustment and monitoring
• Elderly patients: Increased susceptibility to NSAID side effects, particularly gastrointestinal bleeding. The lowest effective dose should be used, and renal function should be monitored
• Asthma: Aspirin-sensitive asthma occurs in approximately 10-20% of adult asthma patients. NSAIDs may trigger bronchospasm in these individuals

Pregnancy and Breastfeeding

The use of Ibukron during pregnancy requires careful consideration based on the trimester:

First and second trimester: Ibukron should only be used if clearly necessary and at the lowest effective dose for the shortest duration. Epidemiological studies suggest a possible increased risk of miscarriage and cardiac malformations with NSAID use in early pregnancy, although the absolute risk remains low.

Third trimester: Ibukron is contraindicated. NSAIDs may cause premature closure of the fetal ductus arteriosus, fetal renal dysfunction leading to oligohydramnios, inhibition of platelet aggregation, and delayed or prolonged labor.

Breastfeeding: Ibuprofen is excreted in breast milk in very small quantities. Due to its short half-life and low milk-to-plasma ratio, ibuprofen is generally considered compatible with breastfeeding at standard therapeutic doses. However, consult your healthcare provider before use.

How Does Ibukron Interact with Other Drugs?

Ibukron interacts with several important drug classes. It should not be combined with other NSAIDs or aspirin (except low-dose aspirin for cardiac protection, under medical supervision). Significant interactions exist with anticoagulants, lithium, methotrexate, ACE inhibitors, diuretics, and SSRIs. Always inform your doctor about all medications you are taking.

Drug interactions with ibuprofen can be pharmacokinetic (affecting absorption, metabolism, or excretion) or pharmacodynamic (affecting the drug's therapeutic or adverse effects). Understanding these interactions is critical for safe prescribing. The following table summarizes the most clinically significant interactions that prescribers and patients should be aware of.

The risk of interactions increases with higher doses and longer treatment durations. Patients taking multiple medications should undergo regular medication reviews, and their healthcare providers should carefully consider potential interactions before adding Ibukron to their treatment regimen.

Major Interactions

The most clinically significant interactions involve drugs where concurrent use with Ibukron may lead to serious or potentially life-threatening consequences. The combination with anticoagulants such as warfarin deserves special attention, as ibuprofen both inhibits platelet aggregation and may displace warfarin from plasma protein binding sites, creating a synergistic increase in bleeding risk. Patients on anticoagulant therapy should generally avoid NSAID use, and if it is unavoidable, close monitoring of INR and signs of bleeding is essential.

The interaction between ibuprofen and low-dose aspirin (used for cardiovascular protection) is of particular clinical importance. Research published in the New England Journal of Medicine has shown that ibuprofen can interfere with aspirin's irreversible platelet inhibition by competing for the COX-1 binding site. If both drugs are necessary, aspirin should be taken at least 30 minutes before ibuprofen, or ibuprofen should be taken at least 8 hours before aspirin to minimize this interaction.

Minor Interactions

Some interactions are of lesser clinical significance but should still be noted. Antacids may slightly delay the absorption of ibuprofen but do not significantly affect the overall bioavailability. Caffeine may modestly enhance the analgesic effect of ibuprofen. Cholestyramine can reduce ibuprofen absorption if taken concurrently, but separating administration by at least 2 hours typically mitigates this effect.

What Is the Correct Dosage of Ibukron?

The standard adult dose of Ibukron is one 400 mg tablet taken three times daily (every 6-8 hours), with a maximum daily dose of 1200 mg (three tablets). Always take with or after food. Use the lowest effective dose for the shortest possible duration. Children under 12 years should not take Ibukron 400 mg.

Dosing of Ibukron should always follow the principle of using the lowest effective dose for the shortest necessary duration. This approach, recommended by both the EMA and FDA, minimizes the risk of dose-dependent adverse effects, particularly gastrointestinal and cardiovascular events. Individual dosing should take into account the severity of the condition, patient age, weight, renal and hepatic function, and concomitant medications.

Adults

For adults aged 18 to 64 years, the recommended dose of Ibukron is one 400 mg film-coated tablet taken three times daily, with at least 6 hours between doses. The tablets should be swallowed whole with a full glass of water and taken with or immediately after food to reduce gastrointestinal irritation. Do not crush or chew the film-coated tablets, as the coating is designed to protect the stomach lining and ensure optimal drug release.

For acute pain conditions such as dental pain or headache, a single 400 mg dose often provides adequate relief within 30 to 60 minutes. If further doses are needed, maintain a minimum interval of 6 hours. In chronic inflammatory conditions such as osteoarthritis, your physician may prescribe doses up to 2400 mg per day (divided into three doses), but this higher dosing should only be used under close medical supervision with regular monitoring.

Children

Ibukron 400 mg film-coated tablets are not recommended for children under 12 years of age. The 400 mg dose is too high for most pediatric patients, and children require weight-based dosing with appropriate formulations such as ibuprofen oral suspension or lower-strength tablets. For children aged 6 months and older, ibuprofen is typically dosed at 5-10 mg/kg every 6-8 hours, with a maximum daily dose of 30 mg/kg. Always consult a pediatrician for appropriate dosing guidance.

Elderly

Elderly patients (65 years and older) are at significantly increased risk of NSAID-related adverse effects, including gastrointestinal bleeding, cardiovascular events, and renal impairment. The British National Formulary (BNF) and international guidelines recommend starting with the lowest effective dose and avoiding prolonged use whenever possible. Baseline renal function assessment and periodic monitoring are advisable. Co-prescription of a proton pump inhibitor (PPI) such as omeprazole should be considered for gastroprotection in elderly patients who require NSAID therapy.

Missed Dose

If you miss a dose of Ibukron, take it as soon as you remember, provided it is not close to the time for your next dose. If it is nearly time for the next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one. Ibukron is typically taken on an as-needed basis for pain, so missed doses are generally not clinically significant.

Overdose

Ibuprofen overdose can be serious, particularly in children. Symptoms of overdose may include nausea, vomiting, abdominal pain, drowsiness, headache, tinnitus (ringing in the ears), and in severe cases, metabolic acidosis, renal failure, seizures, and loss of consciousness. If you suspect an overdose, seek immediate medical attention or contact your local poison control center. There is no specific antidote for ibuprofen overdose; treatment is supportive and symptomatic, including gastric decontamination if the patient presents early.

What Are the Side Effects of Ibukron?

The most common side effects of Ibukron include gastrointestinal symptoms such as stomach pain, nausea, dyspepsia, and diarrhea. Less common effects include headache, dizziness, and skin rash. Serious but rare side effects include gastrointestinal bleeding, cardiovascular events (heart attack, stroke), severe skin reactions, and kidney injury. Seek medical attention immediately if you experience black stools, severe stomach pain, chest pain, or breathing difficulties.

As with all NSAIDs, Ibukron may cause a range of side effects. The likelihood and severity of side effects are generally dose-dependent and increase with longer treatment duration. Most mild side effects resolve upon dose reduction or discontinuation of the drug. Understanding the frequency and nature of potential adverse effects helps patients and healthcare providers make informed treatment decisions.

The side effects listed below are categorized according to standard pharmacovigilance frequency classifications used by the EMA: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), and rare (<1/1,000).

It is important to note that the cardiovascular and gastrointestinal risks associated with NSAIDs are class effects. A large-scale meta-analysis published in The Lancet (Coxib and traditional NSAID Trialists' Collaboration, 2013) found that high-dose ibuprofen (2400 mg/day) was associated with an increased risk of major coronary events, comparable to COX-2 selective inhibitors. However, at lower doses typically used for acute pain (such as the 1200 mg/day maximum with Ibukron), the cardiovascular risk appears to be lower. Nonetheless, patients with established cardiovascular disease should use NSAIDs only after careful risk-benefit assessment.

How Should You Store Ibukron?

Store Ibukron at room temperature below 25°C (77°F), in the original packaging to protect from moisture and light. Keep out of reach and sight of children. Do not use after the expiration date printed on the packaging.

Proper storage of medications is essential to maintain their efficacy and safety throughout the shelf life. Ibuprofen film-coated tablets are stable under standard storage conditions, but exposure to excessive heat, moisture, or light can degrade the active ingredient and compromise the protective film coating.

Store Ibukron in its original blister packaging or container at room temperature, ideally between 15°C and 25°C (59°F to 77°F). Avoid storing in bathrooms or kitchens where humidity levels fluctuate significantly. Do not transfer tablets to another container unless it provides equivalent protection from moisture and light.

Check the expiration date regularly and dispose of any expired medication. Do not use Ibukron if the tablets appear discolored, damaged, or have an unusual odor. Return expired or unwanted medication to your pharmacy for safe disposal in accordance with local regulations. Never flush medications down the toilet or discard them in household waste unless instructed to do so by your pharmacist.

What Does Ibukron Contain?

Each Ibukron film-coated tablet contains 400 mg of ibuprofen as the active ingredient. The tablets also contain inactive ingredients (excipients) used for manufacturing, stability, and coating purposes. If you have known allergies to any pharmaceutical excipients, check the full ingredient list with your pharmacist.

The active pharmaceutical ingredient in Ibukron is ibuprofen, a racemic mixture of R(-) and S(+) enantiomers. Only the S(+) enantiomer (also known as dexibuprofen) is pharmacologically active, but following oral administration, the inactive R(-) form is partially converted to the active S(+) form in the body. This conversion occurs via a unidirectional chiral inversion mechanism, meaning that both enantiomers ultimately contribute to the therapeutic effect.

The film-coated tablet formulation provides several advantages. The film coating protects the tablet core from moisture, masks any unpleasant taste, and facilitates swallowing. It may also provide a degree of enteric protection, reducing direct contact between ibuprofen and the gastric mucosa, although this does not eliminate the systemic gastrointestinal effects of the drug.

Common excipients found in ibuprofen film-coated tablets typically include:

• Tablet core: Microcrystalline cellulose, croscarmellose sodium (disintegrant), lactose monohydrate, povidone (binder), magnesium stearate (lubricant), colloidal silicon dioxide (glidant)
• Film coating: Hypromellose, titanium dioxide (E171), macrogol/polyethylene glycol, talc

Patients with lactose intolerance should be aware that some ibuprofen formulations contain lactose monohydrate, although the amounts present are generally too small to cause symptoms in most lactose-intolerant individuals. If you have known allergies to any pharmaceutical excipients (such as colorants or preservatives), consult your pharmacist for the complete excipient list specific to the Ibukron product available in your region.